Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kewaunee Scientific (KEQU) Change in Accured Expenses (2016 - 2026)

Kewaunee Scientific (KEQU) has 16 years of Change in Accured Expenses data on record, last reported at -$4.9 million in Q4 2025.

  • For Q4 2025, Change in Accured Expenses fell 506.97% year-over-year to -$4.9 million; the TTM value through Oct 2025 reached -$1.9 million, down 234.56%, while the annual FY2025 figure was $583000.0, 15.63% down from the prior year.
  • Change in Accured Expenses reached -$4.9 million in Q4 2025 per KEQU's latest filing, down from -$1.5 million in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $7.5 million in Q1 2022 and bottomed at -$5.1 million in Q3 2024.
  • Average Change in Accured Expenses over 5 years is $67850.0, with a median of $249000.0 recorded in 2021.
  • Peak YoY movement for Change in Accured Expenses: skyrocketed 1508.02% in 2022, then plummeted 2162.39% in 2024.
  • A 5-year view of Change in Accured Expenses shows it stood at $2.1 million in 2021, then crashed by 304.82% to -$4.3 million in 2022, then decreased by 3.24% to -$4.4 million in 2023, then soared by 127.2% to $1.2 million in 2024, then tumbled by 506.97% to -$4.9 million in 2025.
  • Per Business Quant database, its latest 3 readings for Change in Accured Expenses were -$4.9 million in Q4 2025, -$1.5 million in Q3 2025, and $5.5 million in Q2 2025.